Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China, providing specialized services for the collection, processing, and long-term cryopreservation of stem cells. The company operates through exclusive licenses in major regions including Beijing, Guangdong, and Zhejiang, serving a massive subscriber base of expectant parents. Its stored cord blood units are utilized in life-saving hematopoietic stem cell transplants for patients with various hematological and genetic disorders. Beyond storage, the company is actively involved in expanding the clinical applications of cord blood-derived stem cells through research and partnerships with medical institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cord Blood Banks.